Vincerx Pharma, Inc. - Common Stock (VINC)

Historical Holders from Q4 2020 to Q1 2025

Symbol
VINC on Nasdaq
CUSIP
92731L106
Type / Class
Equity / Common Stock
All holders as of March 31, 2025
Q1 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-20
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vincerx Pharma, Inc. - Common Stock (VINC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SAGE RHINO CAPITAL LLC 0% $426 4.26K Sage Rhino Capital, LLC Jan 29, 2025

Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$1.26M 0
2024 Q4 4.8M $1.26M -$3.37M $0.26 20
2024 Q3 11M $7.89M +$210K $0.72 26
2024 Q2 10.7M $8.66M -$5.38M $0.81 26
2024 Q1 8.45M $42.7M -$724K $5.06 35
2023 Q4 9.8M $11.6M -$1.03M $1.18 31
2023 Q3 10.7M $10.8M -$1.89M $1.01 35
2023 Q2 12.1M $15.7M -$936K $1.30 34
2023 Q1 12.8M $13.3M +$58.3K $1.04 35
2022 Q4 12.8M $13M -$2.53M $1.02 34
2022 Q3 14.5M $20M +$814K $1.38 41
2022 Q2 13.9M $18.3M -$8.26M $1.32 43
2022 Q1 16.2M $65M -$3.58M $4.00 64
2021 Q4 15.4M $157M -$9.73M $10.19 55
2021 Q3 15.4M $249M +$55.4M $16.17 55
2021 Q2 12.1M $157M +$36.2M $12.99 55
2021 Q1 8.86M $171M +$96.1M $19.30 36
2020 Q4 3.8M $79.5M +$68M $20.91 18